Antithrombin III

"Antithrombin III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.

Descriptor ID	D000990
MeSH Number(s)	D12.644.861.060.500 D12.776.124.790.106.125 D12.776.377.715.085.125 D12.776.872.060.500 D23.113.025
Concept/Terms	Antithrombin III Antithrombin III Heparin Co-Factor I Heparin Co Factor I Serpin C1 Heparin Cofactor I Cofactor I, Heparin Atenativ Atenativ Thrombate III Thrombate III Antithrombin III-Alpha Antithrombin III-Alpha Antithrombin III Alpha Antithrombin IIIAlpha Kybernin Kybernin

Below are MeSH descriptors whose meaning is more general than "Antithrombin III".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Serpins [D12.644.861]
Antithrombin Proteins [D12.644.861.060]
Antithrombin III [D12.644.861.060.500]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Serum Globulins [D12.776.124.790]
Alpha-Globulins [D12.776.124.790.106]
Antithrombin III [D12.776.124.790.106.125]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Alpha-Globulins [D12.776.377.715.085]
Antithrombin III [D12.776.377.715.085.125]
Serpins [D12.776.872]
Antithrombin Proteins [D12.776.872.060]
Antithrombin III [D12.776.872.060.500]
Biological Factors [D23]
Blood Coagulation Factor Inhibitors [D23.113]
Antithrombin III [D23.113.025]

Below are MeSH descriptors whose meaning is more specific than "Antithrombin III".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antithrombin III" by people in this website by year, and whether "Antithrombin III" was a major or minor topic of these publications.

Bar chart showing 10 publications over 8 distinct years, with a maximum of 2 publications in 1994 and 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1994	0	2	2
1997	0	1	1
1999	0	1	1
2001	1	0	1
2002	0	1	1
2006	1	1	2
2015	0	1	1
2017	0	1	1

Below are the most recent publications written about "Antithrombin III" by people in Profiles.

Wang J, Sun Z, Gou W, Adams DB, Cui W, Morgan KA, Strange C, Wang H. a-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction. Diabetes. 2017 04; 66(4):970-980.

View in: PubMed
Whelihan MF, Lim MY, Mooberry MJ, Piegore MG, Ilich A, Wogu A, Cai J, Monroe DM, Ataga KI, Mann KG, Key NS. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease. J Thromb Haemost. 2016 10; 14(10):1941-1952.

View in: PubMed
Hyacinth HI, Adams RJ, Greenberg CS, Voeks JH, Hill A, Hibbert JM, Gee BE. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke. PLoS One. 2015; 10(8):e0134193.

View in: PubMed
Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke. 2006 Jul; 37(7):1798-804.

View in: PubMed
Becker RC, Alexander JH, Dyke C, Huang Y, Saint-Jacques H, Hasselblad V, Harrington RA, Bovill EG. Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease. Thromb Res. 2006; 117(4):439-46.

View in: PubMed
Gaca JG, Lesher A, Aksoy O, Gonzalez-Stawinski GV, Platt JL, Lawson JH, Parker W, Davis RD. Disseminated intravascular coagulation in association with pig-to-primate pulmonary xenotransplantation. Transplantation. 2002 Jun 15; 73(11):1717-23.

View in: PubMed
Slaughter TF, Mark JB, El-Moalem H, Hayward KA, Hilton AK, Hodgins LP, Greenberg CS. Hemostatic effects of antithrombin III supplementation during cardiac surgery: results of a prospective randomized investigation. Blood Coagul Fibrinolysis. 2001 Jan; 12(1):25-31.

View in: PubMed
Ragosta M, Karve M, Brezynski D, Humphries J, Sanders JM, Sarembock IJ, Gimple LW, Powers ER. Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention. Am Heart J. 1999 Feb; 137(2):250-7.

View in: PubMed
Slaughter TF, Faghih F, Greenberg CS, Leslie JB, Sladen RN. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg. 1997 Dec; 85(6):1221-6.

View in: PubMed
Greenberg CS, Hursting MJ, Macik BG, Ortel TL, Kane WH, Moore BM. Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2. Clin Chem. 1994 Oct; 40(10):1962-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals